Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-21 to 2024-10-31
Current total value of award: $89.2
Description: 8510969192!DILTIAZEM HYDROCHLO